Bath & Body Works, Inc. Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q3 FY202510-Q · 2025-10-31 | $1.6B | — | $77.0M | — | $161.0M | $0.37 |
| Q2 FY202510-Q · 2025-07-31 | $167.0M | — | $64.0M | — | $157.0M | $0.30 |
| Q1 FY202510-Q · 2025-04-30 | $1.1B | — | $105.0M | — | $209.0M | $0.49 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q3 FY202510-Q | $5.0B | — | $236.0M | -$1.6B |
| Q2 FY202510-Q | $4.8B | — | $364.0M | -$1.5B |
| Q1 FY202510-Q | $4.9B | — | $636.0M | -$1.5B |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q3 FY202510-Q | $161.0M | $77.0M | $658.0M | 205,000,000 |
| Q2 FY202510-Q | $157.0M | $64.0M | $640.0M | 208,000,000 |
| Q1 FY202510-Q | $209.0M | $105.0M | $646.0M | 212,000,000 |
Filings
(4)Methodology
Every figure on this page is pulled directly from Bath & Body Works, Inc.'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].